Skip to main content
. 2014 Feb 17;18(1):R34. doi: 10.1186/cc13731

Table 1.

Patient characteristics

Variable Total population (n = 101)
Demographics
 
Gender, male, n (%)
61 (60.4)
Age, years, median (IQR)
78 (72 to 83)
Examination variables
 
Respiratory rate, acts/minute, median (IQR)
24 (22 to 28)
Body temperature,°C, median (IQR)
38.4 (36 to 38.7)
Glasgow Coma Scale, points, median (IQR)
15 (10 to 15)
Mean arterial pressure, mm Hg, median (IQR)
83.3 (74 to 93)
Past medical history
 
Cardiovascular, yes, n (%)
26 (25.7)
Hypertensive, yes, n (%)
47 (46.5)
Diabetes, yes, n (%)
35 (34.7)
Cancer, yes, n (%)
13 (12.9)
Labaratory variables
 
ADM, pg/mL, median (IQR)
53.8 (37.4 to 94.0)
PCT, ng/mL, median (IQR)
2.8 (0.6 to 10.7)
Creatinine clearance, mL/minute, median (IQR)
48 (23 to 77)
Creatinine, mg/dL, median (IQR)
1.3 (0.9 to 2.4)
CRP, mg/dL, median (IQR)
16 (6.6 to 25.6)
White cells, 109 cells/L, median (IQR)
12.7 (6.8 to 17.6)
Platelets, 109 cells/L, median (IQR)
213 (150 to 278)
Other
 
Final diagnosis, severe sepsis/shock, n (%)
29 (28.7)
Length of stay, days, median (IQR)
5 (2 to 7)
Septic shock at arrival, yes, n (%)
25 (24.8)
Acute organ dysfunction, yes, n (%)
39 (38.6)
APACHE II score, points, median (IQR)
16 (13 to 21)
Treatment at baseline
 
Steroids, yes, n (%)
16 (15.8)
Vasopressors, yes, n (%)
18 (17.8)
Antibiotics, yes, n (%)
101 (100)
Fluid therapy, yes, n (%) 101 (100)

ADM, Adrenomedullin; PCT, Procalcitonin; CRP, C-reactive protein.